test3

Medical Device Industry News

Welcome! Medical Device News Magazine brings you the latest medical device industry news, clinical trials and updates, product launches, profiles of device companies, acquisitions, executives on the move, non-profit and medical society news and more. Read by practicing medical specialists, industry executives, investors and other allied health professional. We invite you to visit the magazine daily! Learn more.

Monday, June 24, 2019
BlueRiver technology enables a broad range of medical AV applications and is leveraged to deliver high quality performance over common off the shelf (COTS) 10G Ethernet switches. Cost-effective, zero-latency AV content enables efficient next-generation medical imaging applications.
The EyeArt AI Eye Screening System is the most extensively validated AI technology for autonomous detection of DR, tested in the real world on more than a half-million patient visits globally with over 2 million images collected in real-world clinical environments.
Final Results Presented during the late-breaking session at the Society for Vascular Surgery Annual Meeting
"While automation in the workplace has improved quality and efficiencies dramatically in modern work environments, many of the remaining manual tasks are often repetitive and can cause injury or other WMSDs (work-related musculoskeletal disorders)," said Kelly Wehner, President of BOSTONtec®. "Finding and retaining workers for these repetitive tasks is becoming increasingly difficult for companies. In a tight labor market employee retention is a major success factor."
A signed and binding agreement to acquire the US-based MRS Systems is in place. Volpara will be able to expand its product portfolio and apply its extensive experience in artificial intelligence & machine learning to revolutionize personalized breast care through new technology development.
“I’m quite encouraged by the highly positive results demonstrated by the Surfacer System,” stated Mahmood Razavi, MD, Interventional Radiologist at St. Joseph Hospital in Orange, California and lead principal investigator of the SAVE-US study.
Over 900 neurosurgeons have attended similar courses in the U.S., Canada and Singapore on Advances in Subcortical Neurosurgery using Minimally Invasive Parafascicular Surgery (MIPS) supported by the BrainPath Approach, NICO's systems approach to addressing both primary and secondary tumors and hemorrhagic stroke -- the deadliest, costliest and most debilitating form of stroke with an annual worldwide incidence rate of 2.1 million.
The VOCAL test is a liquid biopsy that combines mass spectrometry and artificial intelligence and machine learning to analyze tumor-associated changes in circulating glycoproteins. The announcement was made at the 2019 ASCO® Annual Meeting in Chicago.
PathMAP Functional Signaling Profiles are highly predictive of individual solid tumor responses to targeted therapies and combinations because they are based on the dynamic, predictive signaling information available only from live cells reports BioMarker Strategies.
"After I was diagnosed with sleep apnea 10 years ago, my CPAP machine changed my life," Shatner said. "But I never really understood how important it was to clean it every day to prevent germs and bacteria. That's why I love my SoClean—it makes it simple to keep the CPAP sanitized."
The researchers used aggregated Centers for Medicare and Medicaid Services claims data to identify recent temporal trends in the use of hemodialysis conduit angiography and thrombectomy procedures at both the national (2001-2015) and state (2004-2015) levels, as well as by specialty and site of service.
The AccuCinch® Ventricular Repair System is designed to complement and enhance the existing care cardiologists provide to further manage symptoms and slow, or stop, the progression of heart failure. For some patients, AccuCinch may have the potential to reverse the enlargement of the left ventricle.
“Restenosis, or re-narrowing of an artery post-procedure, is a major problem for my patients,” said C.V. Ramana, MD, principal study investigator. “In my experience, DABRA has provided a highly effective treatment, with minimal vascular trauma, which I believe leads to lower rates of restenosis and longer lasting results,” Dr. Ramana practices at NAADI Healthcare in Oklahoma City, OK.
The enterprise SurgicalAR platform integrates the latest advancements in augmented reality, artificial intelligence, and computer vision to advance surgical visualization, thereby decreasing surgical complications and improving patient outcomes — all while lowering costs to the healthcare system.
The updated version (R2.0) now reflects new language and context of the regulation since the first Implementation Guideline was published in 2014.
For most, knee replacement surgery is a difficult option, with a painful recovery and a long, rigorous rehabilitation period. Now the superior accuracy and precision of the RSIP Vision AI solution, unmatched in the market today, revolutionizes knee surgery to provide remarkably improved outcomes for patients. By helping surgeons match patients with the best possible implants, the groundbreaking technology offers patients far greater comfort, less pain, and a faster road to full mobility.
Fabrice Chaumard, Sales and Marketing Director of MR Solutions said: “It was very gratifying to not only have great interest from new customers but report backs from existing customers on the quality of the images, the stability and robustness of the technology.”
The panel presentations and deliberations addressed a wide range of considerations related to paclitaxel drug-coated balloons (DCB) and drug-eluting stents (DES). Laura Mauri, M.D., vice president, Global Clinical Research & Analytics, Medtronic also presented alongside Dan Clair, M.D., chair of the Department of Surgery for the University of South Carolina (USC) and the Palmetto Health-USC Medical Group and Eric A. Secemsky, M.D., MSc, RPVI, FACC, FVSM, Beth Israel Deaconess Medical Center, Harvard Medical as part of an unprecedented pan-industry presentation.
The RATULS trial confirmed the finding of previous research studies which demonstrated that robot-assisted therapy improved upper limb impairment when compared with conventional care methods for stroke victims.
“With the closing of this round, we have established a strong financial foundation from which to leverage the significant growth opportunities ahead of us and achieve long-term commercial viability,” said Skip Baldino, President and CEO of EndoGastric Solutions.
"We should all check our bodies for cancer as part of our routine health regimen. To make that possible, we're aiming to combine a  better patient experience with the most advanced medical imaging technology and the latest developments in artificial intelligence," said Emi Gal, CEO & co-founder of Ezra. "Our goal is to improve the speed, accuracy and affordability of cancer screening, and I'm thrilled to be announcing our full-body MRI-based cancer screening program." 
This approval means Kelyniam can now sell the only approved PEEK cranial implant with an integrated fixation system (IFS).  IFS Tabs© can eliminate the need for cranioplasty plates, saving hundreds of dollars per procedure. Surgeons can determine where the fixation tabs are placed around the implant to ensure a precise fit.    
TSolution One® Total Knee Application uses a CT-based 3D pre-surgical planning program for the surgeon to design and prepare, in a virtual environment, the patient's unique knee joint replacement plan using a selection of knee implant options.
Roy Johnson, Micrima’s Executive Chairman, said: “This is an exciting step for Micrima as we transition from the product development phase into the market. We are pleased to be working with one of the best recognised global companies in breast imaging, and look forward to launching MARIA® into further new territories.”
“We are particularly excited with this fourth system installation at HSS as it demonstrates the significant value of our patient-specific solutions at such a significant and prominent location and across multiple specialties including pediatric, spine, hip joint replacement, and sports medicine,” stated Mike Lobinsky, Chief Executive Officer of EOS imaging.
The ControlRad Trace is the only technology that can be integrated into existing mobile C-arms to reduce radiation in any fluoroscopic imaging procedure.
The First-In-Human study aimed to demonstrate safety, feasibility and acute performance of the Leaflex™ catheter as a standalone treatment, and included sixteen (16) transfemoral cases where Leaflex™ was used prior to TAVR.
The Epic marketplace integration allows patients to use the TytoCare examination device and consumer app in a unified workflow with Epic's MyChart patient app. Healthcare providers, in turn, can perform remote medical exams using TytoCare and leverage the exam data to conduct comprehensive telehealth visits and physical assessments. Upon completion of the telehealth visit, exam data captured by TytoCare is automatically transferred to Epic's electronic health record.
“Previous estimates stated 100 million worldwide have sleep apnea. Now we know it’s nearly double that in just the Americas alone,” said study coauthor and ResMed Chief Medical Officer Carlos M. Nunez, M.D.
The Life Image and Bialogics partnership will streamline access to analytics of medical imaging in order to help provider organizations enhance operational and financial performance, and improve patient satisfaction.

Market Reports

Global Prosthetic Heart Valves Market Analysis 2015-2019 & Forecast to 2024

The report analyzes the worldwide markets for Prosthetic Heart Valves in US$ by the following Segments: Tissue Heart Valves, Transcatheter Heart Valves, and Mechanical Heart Valves.

Urological Catheters Markets, 2017-2018 & 2019-2025

This urological catheters markets report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America. Annual estimates and forecasts are provided for the period 2017 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

European Magnetic Resonance Imaging Market 2019-2024 is Projected to Reach $3.99 Billion

The Europe MRI market is projected to grow at a CAGR of 1.37% to reach US$3.999 billion by 2024, from US$3.686 billion in 2018 The...

Hemodialysis Vascular Grafts Market Size Worth $276.5 Million By 2025

Increasing number of patients suffering from chronic kidney diseases (CKD) and growing adoption of biological access products due to technological advancements in the field are some of the factors contributing to revenue growth. Higher number of renal impaired patients and limited availability of suitable kidney donors are promoting hemodialysis procedures in renal impaired patients, which in turn is expected to fuel the demand for vascular grafts over the forecast period.

Global Radiosurgery Robotic Systems Market 2019-2025

The report on the global radiosurgery robotic systems market provides qualitative and quantitative analysis for the period from 2017 to 2025.

Non-Profit News

Jeff Shuren, M.D., J.D., Statement on FDA Efforts to Increase Transparency in Medical Device Reporting

U.S. Food and Drug Administration's Center for Devices and Radiological Health is taking a number of important steps to update its Medical Device Reporting (MDR) Program, one of the tools the FDA uses to monitor device performance, detect potential device-related safety concerns or signals and contribute to the benefit-risk assessment of these products.

AAOS Opposition Statement to Senate HELP Surprise Billing Proposal

President Kristy L. Weber, MD, “While the AAOS supports removing patients from the middle of out-of-network billing disputes, we strongly believe that imposing an insurer-controlled rate is not the solution. The Lower Health Care Costs Act represents an unprecedented transfer of market power by the government to insurers and directly threatens the independent practice of medicine."

ACC Names First Director of Diversity and Inclusion

The American College of Cardiology welcomes Ranna Parekh, MD, MPH, as its first Director of Diversity and Inclusion. By working with the ACC Task Force on Diversity and Inclusion and other societies and organizations, Parekh will lead and expand the College’s diversity and inclusion initiatives to create a more diverse and inclusive environment within the field of cardiovascular disease and strive for a fully inclusive organization and profession.

Executives

CEO reports substantial personnel growth in the company’s Pittsburgh office, the company’s Center of Excellence for MRI Coil Repair and Radiography.  To adjust to client needs and the growing demand for sustainable MRI coil repairs, the following personnel updates have been made.
Dr. Americus Reed II is an identity theorist & researcher in the field of marketing. He is the Whitney M. Young, Jr., Professor of Marketing at the Wharton School, University of Pennsylvania, where he has served on the faculty for two decades.
"I am pleased to announce that Claude LeDuc is joining our company," stated Steve Saviuk, Chairman of the Board of Directors of Ortho RTi. "Mr. LeDuc has an outstanding track record of accomplishment in growing private and publicly traded bio-pharma companies. He is taking the helm of Ortho RTi as the Company is commencing preparation for its first human trial to test its lead biopolymer, Ortho-R, for the treatment of Rotator Cuff injuries. Under his leadership we look to the future with excitement and confidence."

RECOMMENDED

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc.

WE WELCOME YOUR VIEWS

Please enter your comment!
Please enter your name here